688319 欧林生物
交易中 11-10 13:48:14
资讯
新帖
简况
欧林生物（688319）披露召开2026年第三季度业绩说明会公告，11月09日股价下跌2.66%
证券之星 · 11-09 22:52
欧林生物（688319）披露召开2026年第三季度业绩说明会公告，11月09日股价下跌2.66%
股市必读：欧林生物新发布《成都欧林生物科技股份有限公司关于持股5%以上股东部分股份解除质押的公告》
证券之星 · 11-09 04:04
股市必读：欧林生物新发布《成都欧林生物科技股份有限公司关于持股5%以上股东部分股份解除质押的公告》
欧林生物（688319）披露持股5%以上股东部分股份解除质押公告，11月06日股价下跌5.72%
证券之星 · 11-06
欧林生物（688319）披露持股5%以上股东部分股份解除质押公告，11月06日股价下跌5.72%
11月6日欧林生物跌5.72%，兴全社会价值三年持有混合基金重仓该股
证券之星 · 11-06
11月6日欧林生物跌5.72%，兴全社会价值三年持有混合基金重仓该股
欧林生物前三季亏损 2021年上市募4亿英大证券保荐
中金财经 · 11-06
欧林生物前三季亏损 2021年上市募4亿英大证券保荐
欧林生物：关于持股5%以上股东部分股份解除质押的公告
同花顺 · 11-05
欧林生物：关于持股5%以上股东部分股份解除质押的公告
11月5日欧林生物涨6.03%，兴全社会价值三年持有混合基金重仓该股
证券之星 · 11-05
11月5日欧林生物涨6.03%，兴全社会价值三年持有混合基金重仓该股
欧林生物（688319）10月30日主力资金净卖出205.03万元
证券之星 · 10-31
欧林生物（688319）10月30日主力资金净卖出205.03万元
欧林生物(688319)9月30日股东户数1.14万户，较上期增加0.73%
证券之星 · 10-30
欧林生物(688319)9月30日股东户数1.14万户，较上期增加0.73%
图解欧林生物三季报：第三季度单季净利润同比下降23.95%
证券之星 · 10-30
图解欧林生物三季报：第三季度单季净利润同比下降23.95%
股市必读：欧林生物新发布《成都欧林生物科技股份有限公司关于收到重组金黄色葡萄球菌疫苗（大肠杆菌）Ⅲ期临床研究总结报告的自愿性披露公告》
证券之星 · 10-21
股市必读：欧林生物新发布《成都欧林生物科技股份有限公司关于收到重组金黄色葡萄球菌疫苗（大肠杆菌）Ⅲ期临床研究总结报告的自愿性披露公告》
10月20日欧林生物涨6.46%，科创创新药ETF国泰基金重仓该股
证券之星 · 10-20
10月20日欧林生物涨6.46%，科创创新药ETF国泰基金重仓该股
欧林生物（688319）10月19日主力资金净卖出502.60万元
证券之星 · 10-20
欧林生物（688319）10月19日主力资金净卖出502.60万元
欧林生物：收到Ⅲ期临床研究总结报告，保护效力73.25%
同花顺 · 10-19
欧林生物：收到Ⅲ期临床研究总结报告，保护效力73.25%
欧林生物（688319）10月12日主力资金净卖出996.00万元
证券之星 · 10-13
欧林生物（688319）10月12日主力资金净卖出996.00万元
10月12日欧林生物跌5.25%，科创创新药ETF国泰基金重仓该股
证券之星 · 10-12
10月12日欧林生物跌5.25%，科创创新药ETF国泰基金重仓该股
股市必读：欧林生物新发布《成都欧林生物科技股份有限公司关于涉及诉讼的进展公告》
证券之星 · 10-12
股市必读：欧林生物新发布《成都欧林生物科技股份有限公司关于涉及诉讼的进展公告》
欧林生物（688319）披露涉及诉讼的进展公告，10月9日股价上涨0.74%
证券之星 · 10-09
欧林生物（688319）披露涉及诉讼的进展公告，10月9日股价上涨0.74%
涉诉事项一审厘清 欧林生物核心反诉获支持
同花顺 · 10-09
涉诉事项一审厘清 欧林生物核心反诉获支持
欧林生物（688319）9月24日主力资金净卖出3464.07万元
证券之星 · 09-25
欧林生物（688319）9月24日主力资金净卖出3464.07万元
加载更多
公司概况
公司名称：
成都欧林生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2021-06-08
主营业务：
成都欧林生物科技股份有限公司的主营业务是创新疫苗的研究、开发、生产及商业化。公司的主要产品是吸附破伤风疫苗、Hib结合疫苗、AC结合疫苗。
发行价格：
9.88
{"stockData":{"symbol":"688319","market":"SH","secType":"STK","nameCN":"欧林生物","latestPrice":28.48,"timestamp":1794289694000,"preClose":27.44,"halted":0,"volume":2374206,"delay":0,"changeRate":0.0379,"floatShares":405000000,"shares":405000000,"eps":-0.079,"marketStatus":"交易中","change":1.04,"latestTime":"11-10 13:48:14","open":27.94,"high":28.53,"low":27.74,"amount":66575400,"amplitude":0.0288,"askPrice":28.48,"askSize":50,"bidPrice":28.46,"bidSize":3,"shortable":0,"etf":0,"ttmEps":-0.079,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1794294000000},"marketStatusCode":2,"adr":0,"adjPreClose":27.44,"symbolType":"stock_kcb","openAndCloseTimeList":[[1794274200000,1794281400000],[1794286800000,1794294000000]],"highLimit":30.18,"lowLimit":24.7,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":405409300,"isCdr":false,"pbRate":12.42,"roa":"--","roe":"--","epsLYR":0.0549,"committee":-0.191304,"marketValue":11546000000,"turnoverRate":0.0059,"status":0,"floatMarketCap":11546000000},"requestUrl":"/m/hq/s/688319/","defaultTab":"news","newsList":[{"id":"2682384377","title":"欧林生物（688319）披露召开2026年第三季度业绩说明会公告，11月09日股价下跌2.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2682384377","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682384377?lang=zh_cn&edition=full","pubTime":"2026-11-09 22:52","pubTimestamp":1794235934,"startTime":"0","endTime":"0","summary":"截至2026年11月9日收盘，欧林生物报收于27.44元，较前一交易日下跌2.66%，最新总市值为111.24亿元。该股当日开盘28.45元，最高28.69元，最低27.41元，成交额达9611.15万元，换手率为0.85%。公告显示，公司将于2026年11月16日15:00-16:00通过上证路演中心网络互动方式召开2026年第三季度业绩说明会，介绍公司经营成果及财务状况。投资者可于2026年11月10日至11月13日16:00前通过上证路演中心网站或公司邮箱ir@olymvax.com提交问题。说明会后可通过该平台查看会议内容。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110900024709.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688319","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682826256","title":"股市必读：欧林生物新发布《成都欧林生物科技股份有限公司关于持股5%以上股东部分股份解除质押的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2682826256","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682826256?lang=zh_cn&edition=full","pubTime":"2026-11-09 04:04","pubTimestamp":1794168251,"startTime":"0","endTime":"0","summary":"公司公告汇总成都欧林生物科技股份有限公司关于持股5%以上股东部分股份解除质押的公告泰昌集团有限公司持有公司股份25,893,040股，占公司总股本6.39%；本次解除质押600,000股，解除后累计质押15,810,000股，占其持股总数61.06%，占公司总股本3.90%；相关手续已于2026年11月6日办理完毕。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110900001163.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688319","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681048898","title":"欧林生物（688319）披露持股5%以上股东部分股份解除质押公告，11月06日股价下跌5.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2681048898","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681048898?lang=zh_cn&edition=full","pubTime":"2026-11-06 23:37","pubTimestamp":1793979447,"startTime":"0","endTime":"0","summary":"截至2026年11月6日收盘，欧林生物报收于28.19元，较前一交易日下跌5.72%，最新总市值为114.28亿元。近日，成都欧林生物科技股份有限公司发布《关于持股5%以上股东部分股份解除质押的公告》。公告显示，公司股东泰昌集团有限公司持有公司股份25,893,040股，占公司总股本的6.39%。本次解除质押股份数量为600,000股，解除质押后，泰昌集团累计质押公司股份15,810,000股，占其持股总数的61.06%，占公司总股本的3.90%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110600039102.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688319","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681664851","title":"11月6日欧林生物跌5.72%，兴全社会价值三年持有混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2681664851","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681664851?lang=zh_cn&edition=full","pubTime":"2026-11-06 17:32","pubTimestamp":1793957571,"startTime":"0","endTime":"0","summary":"证券之星消息，11月6日欧林生物跌5.72%，收盘报28.19元，换手率1.19%，成交量4.82万手，成交额1.38亿元。重仓欧林生物的公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2026基金Q3季报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为兴证全球基金的兴全社会价值三年持有混合。兴全社会价值三年持有混合的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110600028974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688319"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681837981","title":"欧林生物前三季亏损 2021年上市募4亿英大证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2681837981","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681837981?lang=zh_cn&edition=full","pubTime":"2026-11-06 15:00","pubTimestamp":1793948408,"startTime":"0","endTime":"0","summary":"中国经济网北京11月6日讯 欧林生物 近日发布的2026年第三季度报告显示，前三季度公司实现营业收入5.99亿元，同比增长18.15%；归属于上市公司股东的净利润-680.16万元，同比下降114.33%；归属于上市公司股东的扣除非经常性损益的净利润1687.36万元，同比下降57.86%；经营活动产生的现金流量净额为-5445.34万元，同比下降264.78%。欧林生物上市首日股价一度达到48.66元，为历史最高点。 欧林生物首次公开发行股票的发行费用为4159.91万元，其中保荐及承销费3013.05万元。","market":"sh","thumbnail":" //caiji3g.cnfol.com/colect/202611/06/20261106765073.jpg","type":0,"news_type":0,"thumbnails":[" //caiji3g.cnfol.com/colect/202611/06/20261106765073.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20261106/32417556.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["161027","BK0239","IPOS","688319"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681027686","title":"欧林生物：关于持股5%以上股东部分股份解除质押的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2681027686","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681027686?lang=zh_cn&edition=full","pubTime":"2026-11-05 20:12","pubTimestamp":1793880720,"startTime":"0","endTime":"0","summary":" 证券日报网讯 11月5日，欧林生物发布公告称，公司于2026年11月5日收到股东泰昌集团《关于部分股份解除质押的通知函》，获悉其所持有本公司的部分股份办理了解 ...","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261105/c681520014.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261105/c681520014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["688319","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681044233","title":"11月5日欧林生物涨6.03%，兴全社会价值三年持有混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2681044233","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681044233?lang=zh_cn&edition=full","pubTime":"2026-11-05 16:54","pubTimestamp":1793868844,"startTime":"0","endTime":"0","summary":"证券之星消息，11月5日欧林生物涨6.03%，收盘报29.9元，换手率1.64%，成交量6.65万手，成交额1.95亿元。重仓欧林生物的公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2026基金Q3季报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为兴证全球基金的兴全社会价值三年持有混合。兴全社会价值三年持有混合的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110500029564.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688319"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679226197","title":"欧林生物（688319）10月30日主力资金净卖出205.03万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2679226197","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679226197?lang=zh_cn&edition=full","pubTime":"2026-10-31 08:13","pubTimestamp":1793405627,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月30日收盘，欧林生物报收于26.28元，上涨3.42%，换手率1.55%，成交量6.3万手，成交额1.67亿元。近5日资金流向一览见下表：欧林生物融资融券信息显示，融资方面，当日融资买入1658.93万元，融资偿还1231.77万元，融资净买入427.16万元。欧林生物主营业务：长期致力于创新疫苗的研究、开发、生产及商业化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100018093.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688319"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679180872","title":"欧林生物(688319)9月30日股东户数1.14万户，较上期增加0.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679180872","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679180872?lang=zh_cn&edition=full","pubTime":"2026-10-30 19:12","pubTimestamp":1793358749,"startTime":"0","endTime":"0","summary":"证券之星消息，近日欧林生物披露，截至2026年9月30日公司股东户数为1.14万户，较6月30日增加83.0户，增幅为0.73%。在生物制品行业个股中，欧林生物股东户数低于行业平均水平，截至9月30日，生物制品行业平均股东户数为3.67万户。从股价来看，2026年6月30日至2026年9月30日，欧林生物区间跌幅为29.1%，在此期间股东户数增加83.0户，增幅为0.73%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000046626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688319"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679239477","title":"图解欧林生物三季报：第三季度单季净利润同比下降23.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679239477","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679239477?lang=zh_cn&edition=full","pubTime":"2026-10-30 04:25","pubTimestamp":1793305544,"startTime":"0","endTime":"0","summary":"证券之星消息，欧林生物2026年三季报显示，前三季度公司主营收入5.99亿元，同比上升18.15%；归母净利润-680.16万元，同比下降114.33%；扣非净利润1687.36万元，同比下降57.86%；其中2026年第三季度，公司单季度主营收入2.38亿元，同比上升18.17%；单季度归母净利润2607.09万元，同比下降23.95%；单季度扣非净利润2693.56万元，同比下降16.66%；负债率57.81%，投资收益12.51万元，财务费用1286.47万元，毛利率92.2%。财报数据概要请见下图:本文数据来源于欧林生物2026年三季报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000006127.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688319"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677181496","title":"股市必读：欧林生物新发布《成都欧林生物科技股份有限公司关于收到重组金黄色葡萄球菌疫苗（大肠杆菌）Ⅲ期临床研究总结报告的自愿性披露公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2677181496","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677181496?lang=zh_cn&edition=full","pubTime":"2026-10-21 01:34","pubTimestamp":1792517648,"startTime":"0","endTime":"0","summary":"公司公告汇总：欧林生物收到重组金黄色葡萄球菌疫苗Ⅲ期临床研究总结报告，显示保护效力为73.25%，P值=0.0001。疫苗在不同年龄、性别亚组中均显示稳定保护效力。安全性数据显示，疫苗组总体不良反应发生率略高，但主要为轻中度、短暂可预期的局部反应，未增加重度不良事件风险。免疫原性结果显示，疫苗可快速诱导多抗原特异性免疫应答，并维持较长时间。该疫苗尚未上市，需完成后续注册申报程序。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100001533.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688319","BK0239","159646"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676665397","title":"10月20日欧林生物涨6.46%，科创创新药ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2676665397","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676665397?lang=zh_cn&edition=full","pubTime":"2026-10-20 16:28","pubTimestamp":1792484906,"startTime":"0","endTime":"0","summary":"证券之星消息，10月20日欧林生物涨6.46%，收盘报27.04元，换手率1.16%，成交量4.71万手，成交额1.28亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共9家，其中持有数量最多的公募基金为国泰基金的科创创新药ETF国泰。科创创新药ETF国泰目前规模为21.97亿元，最新净值0.7911，较上一交易日上涨0.57%，近一年下跌15.29%。科创创新药ETF国泰的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000024466.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["589720","BK0239","688319"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676637523","title":"欧林生物（688319）10月19日主力资金净卖出502.60万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2676637523","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676637523?lang=zh_cn&edition=full","pubTime":"2026-10-20 08:31","pubTimestamp":1792456269,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月19日收盘，欧林生物报收于25.4元，下跌3.27%，换手率0.89%，成交量3.6万手，成交额9176.04万元。近5日资金流向一览见下表：欧林生物融资融券信息显示，融资方面，当日融资买入875.61万元，融资偿还1005.0万元，融资净偿还129.4万元。欧林生物主营业务：长期致力于创新疫苗的研究、开发、生产及商业化。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000005355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688319","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676685533","title":"欧林生物：收到Ⅲ期临床研究总结报告，保护效力73.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676685533","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676685533?lang=zh_cn&edition=full","pubTime":"2026-10-19 20:02","pubTimestamp":1792411320,"startTime":"0","endTime":"0","summary":"10月19日，欧林生物(688319.SH)公告，公司重组金葡菌疫苗于2026年7月完成Ⅲ期临床试验揭盲，近日收到Ⅲ期临床研究总结报告。报告显示，疫苗在闭合性骨折手术后42天内预防金黄色葡萄球菌感染 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261019/c680848784.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261019/c680848784.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["688319","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675198386","title":"欧林生物（688319）10月12日主力资金净卖出996.00万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675198386","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675198386?lang=zh_cn&edition=full","pubTime":"2026-10-13 08:32","pubTimestamp":1791851523,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月12日收盘，欧林生物报收于28.51元，下跌5.25%，换手率0.99%，成交量4.0万手，成交额1.16亿元。近5日资金流向一览见下表：欧林生物融资融券信息显示，融资方面，当日融资买入804.5万元，融资偿还1106.45万元，融资净偿还301.95万元。欧林生物主营业务：人用疫苗产品研发、生产、销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300007160.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688319","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674647878","title":"10月12日欧林生物跌5.25%，科创创新药ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2674647878","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674647878?lang=zh_cn&edition=full","pubTime":"2026-10-12 16:40","pubTimestamp":1791794427,"startTime":"0","endTime":"0","summary":"证券之星消息，10月12日欧林生物跌5.25%，收盘报28.51元，换手率0.99%，成交量4.0万手，成交额1.16亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共9家，其中持有数量最多的公募基金为国泰基金的科创创新药ETF国泰。科创创新药ETF国泰目前规模为21.97亿元，最新净值0.8498，较上一交易日下跌0.98%，近一年下跌14.78%。科创创新药ETF国泰的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200021764.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688319","589720"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674846837","title":"股市必读：欧林生物新发布《成都欧林生物科技股份有限公司关于涉及诉讼的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674846837","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674846837?lang=zh_cn&edition=full","pubTime":"2026-10-12 03:06","pubTimestamp":1791745577,"startTime":"0","endTime":"0","summary":"公司公告汇总：欧林生物收到成都中院一审判决，确认《技术转让合同》于2026年1月27日解除，公司需实际支付王建华100万元，判决尚在上诉期、未生效。公司公告汇总成都欧林生物科技股份有限公司关于涉及诉讼的进展公告成都欧林生物科技股份有限公司于2026年10月8日收到成都市中级人民法院一审判决书，案涉《技术转让合同》于2026年1月27日解除。本诉及反诉其他请求被驳回。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200000997.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688319"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674850264","title":"欧林生物（688319）披露涉及诉讼的进展公告，10月9日股价上涨0.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674850264","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674850264?lang=zh_cn&edition=full","pubTime":"2026-10-09 22:34","pubTimestamp":1791556455,"startTime":"0","endTime":"0","summary":"截至2026年10月9日收盘，欧林生物报收于30.09元，较前一交易日上涨0.74%，最新总市值为121.99亿元。该股当日开盘29.63元，最高30.36元，最低28.6元，成交额达1.63亿元，换手率为1.37%。近日，成都欧林生物科技股份有限公司发布《关于涉及诉讼的进展公告》。公告显示，公司于2026年10月8日收到成都市中级人民法院一审判决书，案涉《技术转让合同》于2026年1月27日解除。本诉及反诉其他请求被驳回。案件尚在上诉期内，判决未生效，最终影响以生效判决为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900038587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688319"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674854522","title":"涉诉事项一审厘清 欧林生物核心反诉获支持","url":"https://stock-news.laohu8.com/highlight/detail?id=2674854522","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674854522?lang=zh_cn&edition=full","pubTime":"2026-10-09 20:30","pubTimestamp":1791549000,"startTime":"0","endTime":"0","summary":"上证报中国证券网讯(记者李少鹏)10月9日晚，欧林生物披露涉诉进展公告，公司作为被告、反诉原告的一起技术转让合同纠纷案一审判决已送达。据公告，法院认定原告构成违约，公司主张解除合同 ...","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261009/c680539011.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261009/c680539011.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["688319","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670419161","title":"欧林生物（688319）9月24日主力资金净卖出3464.07万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670419161","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670419161?lang=zh_cn&edition=full","pubTime":"2026-09-25 08:22","pubTimestamp":1790295773,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月24日收盘，欧林生物报收于31.52元，下跌7.08%，换手率2.63%，成交量10.64万手，成交额3.45亿元。近5日资金流向一览见下表：欧林生物融资融券信息显示，融资方面，当日融资买入3202.33万元，融资偿还2427.68万元，融资净买入774.65万元，连续3日净买入累计2372.3万元。欧林生物主营业务：人用疫苗产品研发、生产、销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092500005083.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688319"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794289697210,"stockEarnings":[{"period":"1week","weight":0.0163},{"period":"1month","weight":-0.0881},{"period":"3month","weight":-0.0426},{"period":"6month","weight":-0.3053},{"period":"1year","weight":0.1967},{"period":"ytd","weight":0.082}],"compareEarnings":[{"period":"1week","weight":0.0063},{"period":"1month","weight":-0.0401},{"period":"3month","weight":-0.0695},{"period":"6month","weight":-0.1371},{"period":"1year","weight":-0.0842},{"period":"ytd","weight":-0.0776}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"成都欧林生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"11403人(较上一季度增加0.73%)","perCapita":"35552股","listingDate":"2021-06-08","address":"四川省成都市郫都区高新区天欣路99号","registeredCapital":"40540万元","survey":" 成都欧林生物科技股份有限公司的主营业务是创新疫苗的研究、开发、生产及商业化。公司的主要产品是吸附破伤风疫苗、Hib结合疫苗、AC结合疫苗。","listedPrice":9.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"欧林生物(688319)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供欧林生物(688319)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"欧林生物,688319,欧林生物股票,欧林生物股票老虎,欧林生物股票老虎国际,欧林生物行情,欧林生物股票行情,欧林生物股价,欧林生物股市,欧林生物股票价格,欧林生物股票交易,欧林生物股票购买,欧林生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"欧林生物(688319)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供欧林生物(688319)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}